Offstream
news

---

Changes

1. American regulators from the Food and Drug Administration confirms that Pfizer's vaccine candidate is 95% effective.
   2020-12-09 03:04:26 (First version)
2. American regulators from the Food and Drug Administration confirm that Pfizer's vaccine candidate is 95% effective.
   (Current version)

---

Related

The U.S. Food and Drug Administration says that it has granted priority review for the vaccine developed by Pfizer and BioNTech. A decision on whether to fully approve the vaccine will likely be made within two months.
2021-07-16

Israeli Prime Minister Naftali Bennett announces that a deal has been reached with Pfizer CEO Albert Bourla, which would see a new shipment of vaccines delivered on August 1.
2021-07-11

South Africa signs a deal with Pfizer to supply 20 million doses of the Pfizer–BioNTech vaccine. The first shipment is expected to arrive in late April.
2021-04-6

Spain receives its first shipment of the Pfizer-BioNTech vaccine tozinameran in Guadalajara, a day before the country begins its vaccination programme.
2020-12-26

President-elect Joe Biden and incoming First Lady Dr. Jill Biden receive their first shot of the Pfizer BioNTech vaccine on live television to reassure Americans of the safety of vaccines. Meanwhile, Vice President-elect Kamala Harris and incoming Second Gentleman Doug Emhoff announce that they will receive their vaccines next week.
2020-12-21

The Food and Drug Administration announces that they have formally approved Tozinameran, the COVID-19 vaccine developed by Pfizer and BioNTech.
2020-12-11

The United Kingdom's National Health Service begins a mass vaccination campaign against COVID-19 using the BNT162b2 vaccine developed by BioNTech and Pfizer. Seniors over the age of 80 and certain healthcare workers will be among the first to receive the vaccine.
2020-12-8

Moderna announces that they will seek approval from the Food and Drug Administration and European regulators such as the European Medicines Agency for their potential vaccine after it showed a 94% effectiveness.
2020-11-30

Pfizer and BioNTech apply for an emergency use authorization from the U.S. Food and Drug Administration for their vaccine. If the application is approved, the vaccine will likely be limited and rolled out in phases.
2020-11-20

Pfizer announces that it has received approval from the Food and Drug Administration for vaccine trials on children at least 12 years old. The trials are expected to begin at the Cincinnati Children's Hospital Medical Center in Ohio.
2020-10-13